Pretreatment Blood–Brain Barrier Damage and Post-Treatment Intracranial Hemorrhage in Patients Receiving Intravenous Tissue-Type Plasminogen Activator
Richard Leigh(Johns Hopkins University), Max Wintermark(University of Maryland, Baltimore), Joanna M. Wardlaw(University of Edinburgh), Argye E. Hillis(Johns Hopkins University), Peter B. Barker(Johns Hopkins University), Götz Thomalla(Universität Hamburg), David S. Liebeskind(UCLA Health), Marc Fisher, Gregory W. Albers(Stanford University), James C. Grotta(Memorial Hermann), Michael H. Lev(Massachusetts General Hospital), Geoffrey A. Donnan(The Royal Melbourne Hospital), A. Gregory Sorensen(eHealth Africa), Stephen M. Davis(The Royal Melbourne Hospital), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Steven Warach(The University of Texas at Austin), Werner Hacke(Heidelberg University), Shyian Jen(Johns Hopkins University), Dong‐Wha Kang(Ulsan College), Kennedy R. Lees(University of Graz), Chelsea S. Kidwell(Georgetown University), Walter J. Koroshetz(Harvard University), Anthony J. Furlan(Society of Interventional Radiology), John W. Krakauer(Santa Fe Institute)
Cited by 92
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k